352 related articles for article (PubMed ID: 25333467)
1. The structure of human prions: from biology to structural models-considerations and pitfalls.
Acevedo-Morantes CY; Wille H
Viruses; 2014 Oct; 6(10):3875-92. PubMed ID: 25333467
[TBL] [Abstract][Full Text] [Related]
2. Structure-function aspects of prion proteins.
Daggett V
Curr Opin Biotechnol; 1998 Aug; 9(4):359-65. PubMed ID: 9720262
[TBL] [Abstract][Full Text] [Related]
3. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
4. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
[TBL] [Abstract][Full Text] [Related]
5. New insights into prion structure and toxicity.
Harris DA; True HL
Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391
[TBL] [Abstract][Full Text] [Related]
6. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
[TBL] [Abstract][Full Text] [Related]
7. A general model of prion strains and their pathogenicity.
Collinge J; Clarke AR
Science; 2007 Nov; 318(5852):930-6. PubMed ID: 17991853
[TBL] [Abstract][Full Text] [Related]
8. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
10. Prion diseases: what is the neurotoxic molecule?
Chiesa R; Harris DA
Neurobiol Dis; 2001 Oct; 8(5):743-63. PubMed ID: 11592845
[TBL] [Abstract][Full Text] [Related]
11. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
12. Scrapie prions: a three-dimensional model of an infectious fragment.
Huang Z; Prusiner SB; Cohen FE
Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
[TBL] [Abstract][Full Text] [Related]
13. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
14. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
15. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
Hara H; Sakaguchi S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
[TBL] [Abstract][Full Text] [Related]
16. Photo-induced crosslinking of prion protein oligomers and prions.
Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
[TBL] [Abstract][Full Text] [Related]
17. Prion diseases and the central dogma of molecular biology.
Hunter N
Trends Microbiol; 1999 Jul; 7(7):265-6. PubMed ID: 10390630
[No Abstract] [Full Text] [Related]
18. Prions: protein only or something more? Overview of potential prion cofactors.
Fasano C; Campana V; Zurzolo C
J Mol Neurosci; 2006; 29(3):195-214. PubMed ID: 17085779
[TBL] [Abstract][Full Text] [Related]
19. Prion strain mutation determined by prion protein conformational compatibility and primary structure.
Angers RC; Kang HE; Napier D; Browning S; Seward T; Mathiason C; Balachandran A; McKenzie D; Castilla J; Soto C; Jewell J; Graham C; Hoover EA; Telling GC
Science; 2010 May; 328(5982):1154-8. PubMed ID: 20466881
[TBL] [Abstract][Full Text] [Related]
20. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
